{
  "DOI": "10.1186/s40246-023-00499-z",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00499-z",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eEarly-onset dementia (EOD), with symptom onset before age 65, has a strong genetic burden. Due to genetic and clinical overlaps between different types of dementia, whole-exome sequencing (WES) has emerged as an appropriate screening method for diagnostic testing and novel gene-finding approaches. We performed WES and C9orf72 repeat testing in 60 well-defined Austrian EOD patients. Seven patients (12%) carried likely disease-causing variants in monogenic genes, PSEN1, MAPT, APP, and GRN. Five patients (8%) were APOE4 homozygote carriers. Definite and possible risk variants were detected in the genes TREM2, SORL1, ABCA7 and TBK1. In an explorative approach, we cross-checked rare gene variants in our cohort with a curated neurodegeneration candidate gene list and identified DCTN1, MAPK8IP3, LRRK2, VPS13C and BACE1 as promising candidate genes. Conclusively, 12 cases (20%) carried variants relevant to patient counseling, comparable to previously reported studies, and can thus be considered genetically resolved. Reduced penetrance, oligogenic inheritance and not yet identified high-risk genes might explain the high number of unresolved cases. To address this issue, we provide complete genetic and phenotypic information (uploaded to the European Genome-phenome Archive), enabling other researchers to cross-check variants. Thereby, we hope to increase the chance of independently finding the same gene/variant-hit in other well-defined EOD patient cohorts, thus confirming new genetic risk variants or variant combinations.\u003c/jats:p\u003e",
  "alternative-id": [
    "499"
  ],
  "article-number": "55",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "6 March 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "31 May 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "17 June 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 4,
      "value": "28 August 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 5,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 6,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1186/s40246-023-00525-0",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "https://doi.org/10.1186/s40246-023-00525-0"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Medical University of Vienna (protocol code 2137/2019, 10.12.2019)."
    },
    {
      "group": {
        "label": "Informed consent",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper” if applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 5,
      "value": "The authors declare that they have no competing interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Silvaieh",
      "given": "Sara",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "König",
      "given": "Theresa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wurm",
      "given": "Raphael",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Parvizi",
      "given": "Tandis",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berger-Sieczkowski",
      "given": "Evelyn",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Goeschl",
      "given": "Stella",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hotzy",
      "given": "Christoph",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wagner",
      "given": "Matias",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berutti",
      "given": "Riccardo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sammler",
      "given": "Esther",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Stögmann",
      "given": "Elisabeth",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zimprich",
      "given": "Alexander",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        6,
        17
      ]
    ],
    "date-time": "2023-06-17T10:01:59Z",
    "timestamp": 1686996119000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        11,
        18
      ]
    ],
    "date-time": "2023-11-18T15:38:46Z",
    "timestamp": 1700321926000
  },
  "funder": [
    {
      "award": [
        "ÖAG 2019-1"
      ],
      "name": "Austrian Alzheimer Society"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        22
      ]
    ],
    "date-time": "2024-04-22T11:07:37Z",
    "timestamp": 1713784057284
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        6,
        17
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            17
          ]
        ],
        "date-time": "2023-06-17T00:00:00Z",
        "timestamp": 1686960000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            6,
            17
          ]
        ],
        "date-time": "2023-06-17T00:00:00Z",
        "timestamp": 1686960000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00499-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00499-z/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00499-z.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        6,
        17
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        6,
        17
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/dad2.12155",
      "author": "J Hoogmartens",
      "doi-asserted-by": "crossref",
      "first-page": "e12155",
      "issue": "1",
      "journal-title": "Alzheimers Dement (Amst)",
      "key": "499_CR1",
      "unstructured": "Hoogmartens J, Cacace R, Van Broeckhoven C. Insight into the genetic etiology of Alzheimer’s disease: a comprehensive review of the role of rare variants. Alzheimers Dement (Amst). 2021;13(1):e12155.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1177/1533317514545825",
      "author": "AI Jarmolowicz",
      "doi-asserted-by": "crossref",
      "first-page": "299",
      "issue": "3",
      "journal-title": "Am J Alzheimers Dis Other Demen",
      "key": "499_CR2",
      "unstructured": "Jarmolowicz AI, Chen HY, Panegyres PK. The patterns of inheritance in early-onset dementia: Alzheimer’s disease and frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2015;30(3):299–306.",
      "volume": "30",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ng0594-74",
      "author": "CM van Duijn",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "499_CR3",
      "unstructured": "van Duijn CM, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nat Genet. 1994;7(1):74–8.",
      "volume": "7",
      "year": "1994"
    },
    {
      "DOI": "10.1086/302553",
      "author": "D Campion",
      "doi-asserted-by": "crossref",
      "first-page": "664",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "499_CR4",
      "unstructured": "Campion D, et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65(3):664–70.",
      "volume": "65",
      "year": "1999"
    },
    {
      "DOI": "10.1212/01.wnl.0000187068.92184.63",
      "author": "JS Goldman",
      "doi-asserted-by": "crossref",
      "first-page": "1817",
      "issue": "11",
      "journal-title": "Neurology",
      "key": "499_CR5",
      "unstructured": "Goldman JS, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817–9.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1038/gim.2017.102",
      "author": "C Blauwendraat",
      "doi-asserted-by": "crossref",
      "first-page": "240",
      "issue": "2",
      "journal-title": "Genet Med",
      "key": "499_CR6",
      "unstructured": "Blauwendraat C, et al. The wide genetic landscape of clinical frontotemporal dementia: systematic combined sequencing of 121 consecutive subjects. Genet Med. 2018;20(2):240–9.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.24869/spsih.2018.216",
      "author": "B Zalar",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "issue": "2",
      "journal-title": "Psychiatr Danub",
      "key": "499_CR7",
      "unstructured": "Zalar B, et al. Clinical exome sequencing in dementias: a preliminary study. Psychiatr Danub. 2018;30(2):216–9.",
      "volume": "30",
      "year": "2018"
    },
    {
      "DOI": "10.14336/AD.2018.0208",
      "author": "Y Xu",
      "doi-asserted-by": "crossref",
      "first-page": "696",
      "issue": "4",
      "journal-title": "Aging Dis",
      "key": "499_CR8",
      "unstructured": "Xu Y, et al. The whole exome sequencing clarifies the genotype- phenotype correlations in patients with early-onset dementia. Aging Dis. 2018;9(4):696–705.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1038/gim.2015.148",
      "author": "K Retterer",
      "doi-asserted-by": "crossref",
      "first-page": "696",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "499_CR9",
      "unstructured": "Retterer K, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18(7):696–704.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "crossref",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "499_CR10",
      "unstructured": "Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1111/acel.13384",
      "author": "M Riaz",
      "doi-asserted-by": "crossref",
      "first-page": "e13384",
      "issue": "6",
      "journal-title": "Aging Cell",
      "key": "499_CR11",
      "unstructured": "Riaz M, et al. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population. Aging Cell. 2021;20(6):e13384.",
      "volume": "20",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S1474-4422(18)30232-1",
      "author": "S Carmona",
      "doi-asserted-by": "crossref",
      "first-page": "721",
      "issue": "8",
      "journal-title": "Lancet Neurol",
      "key": "499_CR12",
      "unstructured": "Carmona S, et al. The role of TREM2 in Alzheimer’s disease and other neurodegenerative disorders. Lancet Neurol. 2018;17(8):721–30.",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.3390/ijms20010081",
      "doi-asserted-by": "crossref",
      "key": "499_CR13",
      "unstructured": "Wolfe CM et al. The role of APOE and TREM2 in Alzheimer's Disease-Current understanding and perspectives. Int J Mol Sci. 2018; 20(1)."
    },
    {
      "DOI": "10.1007/s00401-019-01994-1",
      "author": "A De Roeck",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "issue": "2",
      "journal-title": "Acta Neuropathol",
      "key": "499_CR14",
      "unstructured": "De Roeck A, Van Broeckhoven C, Sleegers K. The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics. Acta Neuropathol. 2019;138(2):201–20.",
      "volume": "138",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00401-019-01991-4",
      "author": "D Campion",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "issue": "2",
      "journal-title": "Acta Neuropathol",
      "key": "499_CR15",
      "unstructured": "Campion D, Charbonnier C, Nicolas G. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol. 2019;138(2):173–86.",
      "volume": "138",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s40478-021-01294-4",
      "author": "A Rovelet-Lecrux",
      "doi-asserted-by": "crossref",
      "first-page": "196",
      "issue": "1",
      "journal-title": "Acta Neuropathol Commun",
      "key": "499_CR16",
      "unstructured": "Rovelet-Lecrux A, et al. Impaired SorLA maturation and trafficking as a new mechanism for SORL1 missense variants in Alzheimer disease. Acta Neuropathol Commun. 2021;9(1):196.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1038/ng.293",
      "author": "MJ Farrer",
      "doi-asserted-by": "crossref",
      "first-page": "163",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "499_CR17",
      "unstructured": "Farrer MJ, et al. DCTN1 mutations in Perry syndrome. Nat Genet. 2009;41(2):163–5.",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.parkreldis.2017.06.004",
      "author": "T Konno",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "journal-title": "Parkinsonism Relat Disord",
      "key": "499_CR18",
      "unstructured": "Konno T, et al. DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord. 2017;41:14–24.",
      "volume": "41",
      "year": "2017"
    },
    {
      "DOI": "10.1146/annurev.cellbio.20.012103.094623",
      "author": "TA Schroer",
      "doi-asserted-by": "crossref",
      "first-page": "759",
      "journal-title": "Annu Rev Cell Dev Biol",
      "key": "499_CR19",
      "unstructured": "Schroer TA. Dynactin. Annu Rev Cell Dev Biol. 2004;20:759–79.",
      "volume": "20",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.celrep.2020.108050",
      "author": "C Haenig",
      "doi-asserted-by": "crossref",
      "first-page": "108050",
      "issue": "7",
      "journal-title": "Cell Rep",
      "key": "499_CR20",
      "unstructured": "Haenig C, et al. Interactome mapping provides a network of neurodegenerative disease proteins and uncovers widespread protein aggregation in affected brains. Cell Rep. 2020;32(7):108050.",
      "volume": "32",
      "year": "2020"
    },
    {
      "DOI": "10.1177/1073858416648307",
      "author": "KG Miller",
      "doi-asserted-by": "crossref",
      "first-page": "232",
      "issue": "3",
      "journal-title": "Neuroscientist",
      "key": "499_CR21",
      "unstructured": "Miller KG. Keeping neuronal cargoes on the right track: new insights into regulators of axonal transport. Neuroscientist. 2017;23(3):232–50.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1523/JNEUROSCI.0436-11.2011",
      "author": "SH Huang",
      "doi-asserted-by": "crossref",
      "first-page": "10602",
      "issue": "29",
      "journal-title": "J Neurosci",
      "key": "499_CR22",
      "unstructured": "Huang SH, et al. JIP3 mediates TrkB axonal anterograde transport and enhances BDNF signaling by directly bridging TrkB with kinesin-1. J Neurosci. 2011;31(29):10602–14.",
      "volume": "31",
      "year": "2011"
    },
    {
      "DOI": "10.1074/jbc.M115.651885",
      "author": "D Watt",
      "doi-asserted-by": "crossref",
      "first-page": "15512",
      "issue": "25",
      "journal-title": "J Biol Chem",
      "key": "499_CR23",
      "unstructured": "Watt D, Dixit R, Cavalli V. JIP3 activates kinesin-1 motility to promote axon elongation. J Biol Chem. 2015;290(25):15512–25.",
      "volume": "290",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ajhg.2018.12.008",
      "author": "K Platzer",
      "doi-asserted-by": "crossref",
      "first-page": "203",
      "issue": "2",
      "journal-title": "Am J Hum Genet",
      "key": "499_CR24",
      "unstructured": "Platzer K, et al. De novo variants in MAPK8IP3 cause intellectual disability with variable brain anomalies. Am J Hum Genet. 2019;104(2):203–12.",
      "volume": "104",
      "year": "2019"
    },
    {
      "DOI": "10.1002/ana.25481",
      "author": "S Iwasawa",
      "doi-asserted-by": "crossref",
      "first-page": "927",
      "issue": "6",
      "journal-title": "Ann Neurol",
      "key": "499_CR25",
      "unstructured": "Iwasawa S, et al. Recurrent de novo MAPK8IP3 variants cause neurological phenotypes. Ann Neurol. 2019;85(6):927–33.",
      "volume": "85",
      "year": "2019"
    },
    {
      "DOI": "10.1083/jcb.201612148",
      "author": "S Gowrishankar",
      "doi-asserted-by": "crossref",
      "first-page": "3291",
      "issue": "10",
      "journal-title": "J Cell Biol",
      "key": "499_CR26",
      "unstructured": "Gowrishankar S, Wu Y, Ferguson SM. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology. J Cell Biol. 2017;216(10):3291–305.",
      "volume": "216",
      "year": "2017"
    },
    {
      "DOI": "10.1002/acn3.582",
      "author": "NS Raghavan",
      "doi-asserted-by": "crossref",
      "first-page": "832",
      "issue": "7",
      "journal-title": "Ann Clin Transl Neurol",
      "key": "499_CR27",
      "unstructured": "Raghavan NS, et al. Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer’s disease. Ann Clin Transl Neurol. 2018;5(7):832–42.",
      "volume": "5",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ajmg.b.32836",
      "author": "JL Hsu",
      "doi-asserted-by": "crossref",
      "first-page": "67",
      "issue": "2",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "499_CR28",
      "unstructured": "Hsu JL, et al. Genetic study of young-onset dementia using targeted gene panel sequencing in Taiwan. Am J Med Genet B Neuropsychiatr Genet. 2021;186(2):67–76.",
      "volume": "186",
      "year": "2021"
    },
    {
      "DOI": "10.3390/ijms20163903",
      "doi-asserted-by": "crossref",
      "key": "499_CR29",
      "unstructured": "Ciani M et al. The missing heritability of sporadic frontotemporal dementia: new insights from rare variants in neurodegenerative Candidate Genes. Int J Mol Sci. 2019; 20(16)."
    },
    {
      "DOI": "10.1016/j.parkreldis.2016.09.008",
      "author": "TS Fan",
      "doi-asserted-by": "crossref",
      "first-page": "36",
      "journal-title": "Parkinsonism Relat Disord",
      "key": "499_CR30",
      "unstructured": "Fan TS, et al. Clinical heterogeneity of LRRK2 p.I2012T mutation. Parkinsonism Relat Disord. 2016;33:36–43.",
      "volume": "33",
      "year": "2016"
    },
    {
      "DOI": "10.1159/000289232",
      "author": "C Wider",
      "doi-asserted-by": "crossref",
      "first-page": "175",
      "issue": "1–3",
      "journal-title": "Neurodegener Dis",
      "key": "499_CR31",
      "unstructured": "Wider C, Dickson DW, Wszolek ZK. Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener Dis. 2010;7(1–3):175–9.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1186/s40478-019-0836-x",
      "author": "MX Henderson",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "issue": "1",
      "journal-title": "Acta Neuropathol Commun",
      "key": "499_CR32",
      "unstructured": "Henderson MX, et al. Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease. Acta Neuropathol Commun. 2019;7(1):183.",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1002/mds.26815",
      "author": "M Sanchez-Contreras",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "issue": "1",
      "journal-title": "Mov Disord",
      "key": "499_CR33",
      "unstructured": "Sanchez-Contreras M, et al. Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration. Mov Disord. 2017;32(1):115–23.",
      "volume": "32",
      "year": "2017"
    },
    {
      "DOI": "10.1002/humu.20668",
      "author": "C Paisan-Ruiz",
      "doi-asserted-by": "crossref",
      "first-page": "485",
      "issue": "4",
      "journal-title": "Hum Mutat",
      "key": "499_CR34",
      "unstructured": "Paisan-Ruiz C, et al. Comprehensive analysis of LRRK2 in publicly available Parkinson’s disease cases and neurologically normal controls. Hum Mutat. 2008;29(4):485–90.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.7554/eLife.12813",
      "doi-asserted-by": "crossref",
      "key": "499_CR35",
      "unstructured": "Steger M et al. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. Elife. 2016; 5."
    },
    {
      "DOI": "10.1126/science.aar5683",
      "author": "DR Alessi",
      "doi-asserted-by": "crossref",
      "first-page": "36",
      "issue": "6384",
      "journal-title": "Science",
      "key": "499_CR36",
      "unstructured": "Alessi DR, Sammler E. LRRK2 kinase in Parkinson’s disease. Science. 2018;360(6384):36–7.",
      "volume": "360",
      "year": "2018"
    },
    {
      "DOI": "10.1042/BCJ20220161",
      "author": "AF Kalogeropulou",
      "doi-asserted-by": "crossref",
      "first-page": "1759",
      "issue": "17",
      "journal-title": "Biochem J",
      "key": "499_CR37",
      "unstructured": "Kalogeropulou AF, et al. Impact of 100 LRRK2 variants linked to Parkinson’s disease on kinase activity and microtubule binding. Biochem J. 2022;479(17):1759–83.",
      "volume": "479",
      "year": "2022"
    },
    {
      "DOI": "10.1007/s00401-021-02325-z",
      "doi-asserted-by": "crossref",
      "key": "499_CR38",
      "unstructured": "Fan Y et al. R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils. Acta Neuropathol. 2021."
    },
    {
      "DOI": "10.1042/BCJ20170803",
      "author": "Y Fan",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "issue": "1",
      "journal-title": "Biochem J",
      "key": "499_CR39",
      "unstructured": "Fan Y, et al. Interrogating Parkinson’s disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils. Biochem J. 2018;475(1):23–44.",
      "volume": "475",
      "year": "2018"
    },
    {
      "DOI": "10.1074/jbc.M104350200",
      "author": "R Yan",
      "doi-asserted-by": "crossref",
      "first-page": "36788",
      "issue": "39",
      "journal-title": "J Biol Chem",
      "key": "499_CR40",
      "unstructured": "Yan R, et al. The transmembrane domain of the Alzheimer’s beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J Biol Chem. 2001;276(39):36788–96.",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng0892-345",
      "author": "M Mullan",
      "doi-asserted-by": "crossref",
      "first-page": "345",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "499_CR41",
      "unstructured": "Mullan M, et al. A pathogenic mutation for probable Alzheimers-disease in the app gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1(5):345–7.",
      "volume": "1",
      "year": "1992"
    },
    {
      "DOI": "10.1016/j.neurobiolaging.2008.06.012",
      "author": "RJ Guerreiro",
      "doi-asserted-by": "crossref",
      "first-page": "725",
      "issue": "5",
      "journal-title": "Neurobiol Aging",
      "key": "499_CR42",
      "unstructured": "Guerreiro RJ, et al. Genetic screening of Alzheimer’s disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging. 2010;31(5):725–31.",
      "volume": "31",
      "year": "2010"
    },
    {
      "DOI": "10.1002/emmm.201100138",
      "author": "L Zhou",
      "doi-asserted-by": "crossref",
      "first-page": "291",
      "issue": "5",
      "journal-title": "EMBO Mol Med",
      "key": "499_CR43",
      "unstructured": "Zhou L, et al. Amyloid precursor protein mutation E682K at the alternative beta-secretase cleavage beta-site increases A beta generation. EMBO Mol Med. 2011;3(5):291–302.",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1038/s41467-019-10101-7",
      "author": "P Li",
      "doi-asserted-by": "crossref",
      "first-page": "2246",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "499_CR44",
      "unstructured": "Li P, et al. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms. Nat Commun. 2019;10(1):2246.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ajhg.2016.01.014",
      "author": "S Lesage",
      "doi-asserted-by": "crossref",
      "first-page": "500",
      "issue": "3",
      "journal-title": "Am J Hum Genet",
      "key": "499_CR45",
      "unstructured": "Lesage S, et al. Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy. Am J Hum Genet. 2016;98(3):500–13.",
      "volume": "98",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s40478-021-01121-w",
      "author": "S Smolders",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Acta Neuropathol Commun",
      "key": "499_CR46",
      "unstructured": "Smolders S, et al. Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease. Acta Neuropathol Commun. 2021;9(1):25.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ajhg.2019.11.012",
      "author": "Z Zhao",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Am J Hum Genet",
      "key": "499_CR47",
      "unstructured": "Zhao Z, et al. UK biobank whole-exome sequence binary phenome analysis with robust region-based rare-variant test. Am J Hum Genet. 2020;106(1):3–12.",
      "volume": "106",
      "year": "2020"
    },
    {
      "DOI": "10.1093/brain/awm320",
      "author": "J Beck",
      "doi-asserted-by": "crossref",
      "first-page": "706",
      "issue": "Pt 3",
      "journal-title": "Brain",
      "key": "499_CR48",
      "unstructured": "Beck J, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131(Pt 3):706–20.",
      "volume": "131",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.trci.2019.09.013",
      "author": "CM Langlois",
      "doi-asserted-by": "crossref",
      "first-page": "705",
      "journal-title": "Alzheimers Dement (N Y)",
      "key": "499_CR49",
      "unstructured": "Langlois CM, et al. Alzheimer’s prevention initiative generation program: development of an APOE genetic counseling and disclosure process in the context of clinical trials. Alzheimers Dement (N Y). 2019;5:705–16.",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.14283/jpad.2023.30",
      "doi-asserted-by": "crossref",
      "key": "499_CR50",
      "unstructured": "Cummings J et al. Lecanemab: appropriate use recommendations. J Prev Alzheimer's Dis. 2023."
    },
    {
      "DOI": "10.1093/bioinformatics/bts526",
      "author": "V Plagnol",
      "doi-asserted-by": "crossref",
      "first-page": "2747",
      "issue": "21",
      "journal-title": "Bioinformatics",
      "key": "499_CR51",
      "unstructured": "Plagnol V, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28(21):2747–54.",
      "volume": "28",
      "year": "2012"
    },
    {
      "DOI": "10.1093/brain/awv268",
      "author": "V Escott-Price",
      "doi-asserted-by": "crossref",
      "first-page": "3673",
      "issue": "Pt 12",
      "journal-title": "Brain",
      "key": "499_CR52",
      "unstructured": "Escott-Price V, et al. Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain. 2015;138(Pt 12):3673–84.",
      "volume": "138",
      "year": "2015"
    },
    {
      "DOI": "10.1093/braincomms/fcz047",
      "author": "A Altmann",
      "doi-asserted-by": "crossref",
      "first-page": "fcz047",
      "issue": "1",
      "journal-title": "Brain Commun",
      "key": "499_CR53",
      "unstructured": "Altmann A, et al. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE. Brain Commun. 2020;2(1):fcz047.",
      "volume": "2",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41467-020-18534-1",
      "author": "Q Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "4799",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "499_CR54",
      "unstructured": "Zhang Q, et al. Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture. Nat Commun. 2020;11(1):4799.",
      "volume": "11",
      "year": "2020"
    },
    {
      "author": "B Fulton-Howard",
      "first-page": "e1",
      "issue": "101",
      "journal-title": "Neurobiol Aging",
      "key": "499_CR55",
      "unstructured": "Fulton-Howard B, et al. Greater effect of polygenic risk score for Alzheimer’s disease among younger cases who are apolipoprotein E-epsilon4 carriers. Neurobiol Aging. 2021;99(101):e1-101.e9.",
      "volume": "99",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.jalz.2018.02.018",
      "author": "CR Jack Jr",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "issue": "4",
      "journal-title": "Alzheimers Dement",
      "key": "499_CR56",
      "unstructured": "Jack CR Jr, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jalz.2017.01.014",
      "author": "SJ Crutch",
      "doi-asserted-by": "crossref",
      "first-page": "870",
      "issue": "8",
      "journal-title": "Alzheimers Dement",
      "key": "499_CR57",
      "unstructured": "Crutch SJ, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13(8):870–84.",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1093/brain/awr179",
      "author": "K Rascovsky",
      "doi-asserted-by": "crossref",
      "first-page": "2456",
      "issue": "Pt 9",
      "journal-title": "Brain J Neurol",
      "key": "499_CR58",
      "unstructured": "Rascovsky K, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain J Neurol. 2011;134(Pt 9):2456–77.",
      "volume": "134",
      "year": "2011"
    },
    {
      "DOI": "10.1212/WNL.0b013e31821103e6",
      "author": "ML Gorno-Tempini",
      "doi-asserted-by": "crossref",
      "first-page": "1006",
      "issue": "11",
      "journal-title": "Neurology",
      "key": "499_CR59",
      "unstructured": "Gorno-Tempini ML, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–14.",
      "volume": "76",
      "year": "2011"
    },
    {
      "DOI": "10.1212/WNL.43.2.250",
      "author": "GC Román",
      "doi-asserted-by": "crossref",
      "first-page": "250",
      "issue": "2",
      "journal-title": "Neurology",
      "key": "499_CR60",
      "unstructured": "Román GC, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993;43(2):250–60.",
      "volume": "43",
      "year": "1993"
    },
    {
      "DOI": "10.1016/S1474-4422(14)70090-0",
      "author": "B Dubois",
      "doi-asserted-by": "crossref",
      "first-page": "614",
      "issue": "6",
      "journal-title": "Lancet Neurol",
      "key": "499_CR61",
      "unstructured": "Dubois B, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–29.",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.1212/WNL.0000000000004058",
      "author": "IG McKeith",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "issue": "1",
      "journal-title": "Neurology",
      "key": "499_CR62",
      "unstructured": "McKeith IG, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89(1):88–100.",
      "volume": "89",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.clinph.2020.04.005",
      "author": "JM Shefner",
      "doi-asserted-by": "crossref",
      "first-page": "1975",
      "issue": "8",
      "journal-title": "Clin Neurophysiol",
      "key": "499_CR63",
      "unstructured": "Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975–8.",
      "volume": "131",
      "year": "2020"
    },
    {
      "DOI": "10.1212/WNL.0b013e31827f0fd1",
      "author": "MJ Armstrong",
      "doi-asserted-by": "crossref",
      "first-page": "496",
      "issue": "5",
      "journal-title": "Neurology",
      "key": "499_CR64",
      "unstructured": "Armstrong MJ, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496–503.",
      "volume": "80",
      "year": "2013"
    },
    {
      "DOI": "10.3109/13506120009146438",
      "author": "H Vanderstichele",
      "doi-asserted-by": "crossref",
      "first-page": "245",
      "issue": "4",
      "journal-title": "Amyloid",
      "key": "499_CR65",
      "unstructured": "Vanderstichele H, et al. Standardization of measurement of beta-amyloid(1–42) in cerebrospinal fluid and plasma. Amyloid. 2000;7(4):245–58.",
      "volume": "7",
      "year": "2000"
    },
    {
      "DOI": "10.1016/S0304-3940(00)01036-3",
      "author": "E Vanmechelen",
      "doi-asserted-by": "crossref",
      "first-page": "49",
      "issue": "1",
      "journal-title": "Neurosci Lett",
      "key": "499_CR66",
      "unstructured": "Vanmechelen E, et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett. 2000;285(1):49–52.",
      "volume": "285",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.neuron.2011.09.010",
      "author": "AE Renton",
      "doi-asserted-by": "crossref",
      "first-page": "257",
      "issue": "2",
      "journal-title": "Neuron",
      "key": "499_CR67",
      "unstructured": "Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–68.",
      "volume": "72",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s00401-021-02325-z",
      "author": "Y Fan",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "issue": "3",
      "journal-title": "Acta Neuropathol",
      "key": "499_CR68",
      "unstructured": "Fan Y, et al. R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils. Acta Neuropathol. 2021;142(3):475–94.",
      "volume": "142",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41598-021-91943-4",
      "author": "X Wang",
      "doi-asserted-by": "crossref",
      "first-page": "12900",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "499_CR69",
      "unstructured": "Wang X, et al. Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10. Sci Rep. 2021;11(1):12900.",
      "volume": "11",
      "year": "2021"
    }
  ],
  "reference-count": 69,
  "references-count": 69,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.21203/rs.3.rs-2662816/v1",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00499-z"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}